PMCPA Social Media Guidance 2023
The PMCPA has published new guidance on social media use for pharmaceutical companies. This covers:
Types of social media content and how it can be shared
Acceptable uses of social media for providing patient support, making company announcements, advertisements and more
Overarching considerations for all social media activity including pharmacovigilance responsibilities and other relevant laws, regulations, and guidelines to follow
It helps set simple expectations of what is required for PV and removes any excuses to not appropriately train staff and turn a blind eye to online sources.
Drive Phase PV is a pharmacovigilance consultancy and provider of pharmacovigilance services, supporting patient safety throughout the life-cycle of our clients' products. Contact us to discuss developing your PV processes or outsourcing. We deliver a tailored packaged to seamlessly fit to your company structure and strategy.